L. Maragakis

Molecular Medicine · 2008–2012

A researcher in the Science corpus: 2 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom L. Maragakis trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Jian Li
  2. Robert A. Bonomo
  3. Matthew E. Falagas
  4. Roger L. Nation

Papers from L. Maragakis's perspective

Ordered by how strongly the researchers L. Maragakis trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. (Clinical Infectious Diseases)
  2. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. (Clinical Infectious Diseases)
  3. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. (Lancet. Infectious Diseases (Print))
  4. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. (Chest)
  5. Metallo-β-Lactamases: the Quiet before the Storm? (Clinical Microbiology Reviews)
  6. Comparative Genomics of Multidrug Resistance in Acinetobacter baumannii (PLoS Genetics)
  7. The epidemiology and control of Acinetobacter baumannii in health care facilities. (Clinical Infectious Diseases)
  8. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. (American Journal of Medicine)
  9. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. (Clinical Infectious Diseases)
  10. Trends in antimicrobial drug development: implications for the future. (Clinical Infectious Diseases)

Their papers